Many other antibodies with very high specificity for solid tumors are available [e.g., anti-CEA antibodies for colorectal carcinomas (CRC), MTC, breast cancers, or lung cancers]. This evidence concerns the gene CEACAM5 and medullary thyroid gland carcinoma.